Inhibikase Therapeutics, Inc.IKTNASDAQ
LOADING
|||
Switch Symbol:
Operating Income Contraction
Trending lower, below historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-28.59M
↓ 176% below average
Average (8y)
$-10.36M
Historical baseline
Range
High:$-405130.00
Low:$-28.59M
CAGR
+61.6%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-28.59M | -42.3% |
| 2023 | $-20.09M | -10.8% |
| 2022 | $-18.13M | -22.8% |
| 2021 | $-14.77M | -423.9% |
| 2020 | $-2.82M | +50.5% |
| 2019 | $-5.70M | -168.5% |
| 2018 | $-2.12M | -423.8% |
| 2017 | $-405130.00 | +33.9% |
| 2016 | $-613288.00 | - |